Effect of hepatic steatosis and associated metabolic comorbidities on health‐related quality of life in people living with HIV
Abstract Hepatic steatosis (HS) related to nonalcoholic fatty liver disease (NAFLD) is increasing globally. In people living with human immunodeficiency virus (PLWH) risk factors of HS are increased. The impact of HS on outcomes and in particular health‐related quality of life (HRQL) in PLWH remains...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2022-08-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1958 |